Vertex Pharmaceuticals · 7 hours ago
Financial Planning & Analysis Senior Manager
Boston, MA
Full-time
Hybrid
Senior Level, Lead/Staff
$134K/yr - $202K/yr
8+ years expVertex Pharmaceuticals is a global biotechnology company that invests in scientific innovation. They are seeking a Senior Manager for their Disease Strategy Finance Team to provide financial and strategic insights, lead standardization in financial reporting, and develop cross-Disease Area financial analyses.
BiotechnologyHealth CareMedicalPharmaceutical
Responsibilities
Lead standardization of DST Finance processes to ensure consistent level of rigor, balance, and transparency for businesses cases, stage-gate reviews, and investment proposals
Lead development and maintenance of reporting tools to communicate financial impact of business cases and integration into regular financial processes
Collaborate with DST Finance leads to develop and maintain disease area-, asset-, and indication-specific financial models
Represent DST Finance across the organization with specific focus on enterprise financial processes, including planner meetings for Budget, Long-Range Plan, and Forecasts
Partner with Global Financial Systems team to develop self-service reporting and tools for high-frequency deliverables
Proactively identify and drive opportunities for process improvement that enhanced decision-making support for Disease Strategy Teams
Represents DST Finance as a center of excellence for all modeling, valuation and ad hoc analysis used for a wide range of decisions, including presentations at Executive Committee level meetings
Support integration of external innovation into DST Finance processes and workflows
Ad-hoc support for Business Development modeling, valuation, and forecasting
Qualification
Required
Bachelor's degree in finance, Business, Economics or Accounting required
8+ years of experience in FP&A, Strategy, or Analytics roles
Deep understanding of, and demonstrated curiosity to learn, biopharmaceutical drug discovery, development, manufacturing, regulation, and commercialization
Expert analytical and financial modeling skills to evaluate a broad range of financial questions – especially valuation and strategic planning
Ability to work independently to answer business questions or create ad-hoc reporting that may be needed
Expertise with Excel and strong PowerPoint skills; experience with Hyperion or other multidimensional database; experience with business intelligence and visualization tools a plus
Excellent communication and presentation skills, with the ability to influence stakeholders at all levels and a proven ability to present complex financial insights to senior stakeholders
Internal consultant mindset with ability to solve problems through pragmatic, creative approaches and leadership to implement ideas through to successful conclusion
Strong communication skills, both written and verbal, and an eagerness to collaborate with colleagues (within or outside of finance) in sharing insights and learnings and partnering to ensure timely execution of project plans
Possesses a continuous improvement mindset, with flexibility and ability to adapt to change
Preferred
MBA and/or other advanced degree preferred
Benefits
Medical, dental and vision benefits
Generous paid time off (including a week-long company shutdown in the Summer and the Winter)
Educational assistance programs including student loan repayment
A generous commuting subsidy
Matching charitable donations
401(k)
Company
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
5001-10000 employees
H1B Sponsorship
Vertex Pharmaceuticals has a track record of offering H1B sponsorships. Please note that this does not
guarantee sponsorship for this specific role. Below presents additional info for your
reference. (Data Powered by US Department of Labor)
Distribution of Different Job Fields Receiving Sponsorship
Represents job field similar to this job
Trends of Total Sponsorships
2025 (188)
2024 (150)
2023 (111)
2022 (164)
2021 (112)
2020 (80)
Funding
Current Stage
Public CompanyTotal Funding
$657.31MKey Investors
Janssen Belgium
2024-07-10Post Ipo Secondary· $1.11M
2022-05-17Post Ipo Equity· $50M
2009-12-03Post Ipo Equity· $443M
Leadership Team
Reshma Kewalramani
CEO and President
Nina Devlin
Senior Vice President, Chief Communications Officer
Recent News
Pharma Letter
2026-02-04
2026-02-03
Company data provided by crunchbase